【レポートの概要（一部）】
1. Report Overview
1.1 Brazil: Pharmaceutical Market Overview
1.2 Brazilian Pharmaceutical Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Main Questions Answered by This Survey
1.6 Who is Our Report For?
1.7 Research and Analysis Methods
1.8 Frequently Asked Questions (FAQs)
1.9 Some Associated Reports
1.10 About Visiongain
2. Introduction to the Brazilian Pharmaceutical Market
2.1 The Brazilian Pharmaceutical Market Overview
2.2 Generics Segment Continues to Grow in Importance
2.3 CNS – The Largest Therapeutic Area in 2015
2.4 Four Domestic Companies in the Top Ten in 2015
3. The Significance of the Brazilian Market
3.1 Brazilian Economy is the Ninth Largest in the World
3.2 Brazil is the Eighth Largest Pharmaceutical Market
3.3 Brazil is the Largest Market in Latin America
3.4 Brazil Qualifies as a ‘Pharmerging’ Country and one of the BRIC Markets
4. Organisation of the Brazilian Pharmaceutical Market
4.1 ANVISA – Brazil’s Equivalent of the FDA
4.2 Other Influential Organisations
4.3 SUS – One of the World’s Largest Public Health Systems
4.4 Private Healthcare Accessed by 25% of the Population
4.5 Private Insurance Market Growing but Costs are Rising
4.6 New Drug Price Adjustment System Introduced
4.7 RENAME Drug Reimbursement System and the Farmácia Popular
4.8 Extensive Network of Pharmacies in Brazil
4.9 Wholesale and Retail Sectors Undergoing Consolidation
4.10 Panpharma is the Top Wholesale Distributor
4.11 Profarma is the Largest Mixed Distributor
4.12 Raia Drogasil is the Leader in the Retail Sector
4.13 Spending on Marketing Approaches $5bn
5. Major Differences in Healthcare Between Regions
5.1 Size and Prosperity of Different Regions
5.2 South-East is the Richest and Most Populous Region
5.3 South Has the Second Highest GDP
5.4 North-East Has the Second Highest Pharmaceutical Market Share
5.5 North is the Largest and Poorest Region
5.6 Mid-West is a Landlocked Region Housing the Nation’s Capital
6. Product Segments in the Brazilian Pharmaceutical Market 2016-2026
6.1 Forecasts for the Originator, Generic and OTC Segments 2015-2026
6.2 Originator Segment Will be Overtaken by Generics
6.2.1 Product Development Partnerships to Reduce Costs
6.2.2 Originator Drugs Threatened by 35% Cheaper Generics
6.3 Generics Drug Segment Forecast 2015-2026 – Continued Rapid Growth
6.3.1 Rapid Expansion of Generic Segment
6.3.2 Generic Companies Aiming for 45% Market Share
6.3.3 Similares Drugs Face Same Pricing Rules as Generics
6.3.4 Counterfeit Drugs Account for 20% of the Market
6.3.5 National Drug Security System to Tackle Counterfeit Drugs
6.3.6 Challenges for the Brazilian Generics Market
6.4 Brazilian Biologics Market
6.4.1 Biosimilars Market to Double in Size by 2017
6.4.2 BiocadBrazil Brings More Biosimilars to Brazil
6.5 OTC Drug Segment Forecast 2015-2026
6.5.1 Analgesics and Multivitamins Favoured by Brazilians
6.5.2 One Sixth of Population Buy Multivitamins
6.5.3 Restrictions on OTC Products Reversed
6.5.4 Consumer Health Treatments Remain Prominent in the Market
7. Therapeutic Areas of the Brazilian Market 2015-2026
7.1 Forecasts for CNS, Cardiovascular, Gastrointestinal/Metabolic, Oncology, Infectious Diseases and Other Therapeutic Areas, 2015-2016
7.2 The Rise of Non-Communicable Diseases
7.3 Market Forecast for CNS Conditions 2015-2026
7.3.1 CNS Conditions Currently the Largest Therapeutic Area
7.3.2 Domestic Companies Target Generic and OTC CNS Products
7.3.3 Foreign Companies Target Analgesics Market
7.3.4 One Fifth of Brazilians Have Suffered Depression
7.3.5 CNS Conditions: Drivers and Restraints
7.4 Market Forecast for Cardiovascular Therapeutic Area, 2015-2026
7.4.1 Rate of Cardiovascular Disease Expected to Triple
7.4.2 Almost One Quarter of the Population are Hypertensive
7.4.3 Statin Revenues Decline with Loss of Patent Protection
7.4.4 Domestic and International Companies Compete in CVS
7.4.5 Cardiovascular Opportunities and Challenges
7.5 Market Forecast for Gastrointestinal/Metabolic Therapeutic Area, 2015-2026
7.5.1 High Prevalence of Diabetes and GI Conditions
7.5.2 Low Awareness of Diabetes Amongst Population
7.5.3 Drive for Domestic Production of Insulin
7.5.4 EMS’s Generic Esomeprazole an Important Addition
7.5.5 Capturing the Gastrointestinal/Metabolic Disease Opportunity
7.6 Market Forecast for Oncology Therapeutic Area, 2015-2026
7.6.1 Cancer Treatment to Become the Leading Therapeutic Area
7.6.2 Increased Coverage of Cancer Care by Private Health Insurance Providers
7.6.3 What are the Commonest Cancers in Brazil?
7.6.4 Biosimilars Will Help Widen Access to Cancer Drugs
7.6.5 Cristália and Libbs Amongst Leading Oncology Companies
7.6.6 Promising Potential of the Oncology Therapeutic Area
7.7 Market Forecast for Infectious Diseases Therapeutic Area, 2015-2026
7.7.1 Vaccines and Antibiotics Lead Therapeutic Area
7.7.2 Brazil Increasingly Manufacturing its Own Vaccines
7.7.3 First Vaccination Programme Against Dengue Fever
7.7.4 Free Access to HIV Care Despite Concerns About Patent Protection
7.7.5 Chagas Disease and Other Tropical Infections
7.7.6 Long-Term Threat From Zika Virus Epidemic
7.7.7 Importance of Infectious Diseases Compared to Chronic Diseases
7.8 Market Forecast for Other Therapeutic Areas, 2015-2026
8. Domestic Companies in the Brazilian Market
8.1 The Top Ten Domestic Pharmaceutical Companies in 2015
8.2 Multinational Companies Still Own the Majority of the Market
8.3 Domestic Sector Actively Encouraged by Government
8.4 Domestic Firms Control 70% of Generics Market
8.5 EMS: Brazil’s Leading Pharmaceutical Company
8.5.1 Separate Divisions for Different Drug Categories
8.5.2 Full Production and R&D Capability
8.5.3 Legrand and Germed are Key Subsidiaries
8.5.4 Targeted Expansion Overseas
8.6 Hypermarcas: Market Leader in OTC and Branded Generics
8.6.1 Neo Quimica: Ranked Third in the Generics Segment
8.6.2 Subsidiaries Include Mantecorp and Brainfarma
8.7 Medley: Generics Company Owned by Sanofi
8.8 Aché: A Major Acquisition Target in Brazil
8.8.1 Anti-Inflammatory Acheflan Was First Drug Developed in Brazil
8.8.2 Involvement of Aché in Acquisitions Process
8.8.3 Part of Bionovis Collaboration
8.9 Eurofarma: Fifth Largest Domestic Company with Plans to Cover 90% of Latin America
8.9.1 Policy to Make Acquisitions in Latin America
8.10 Teuto Operates Largest Pharmaceutical Complex in Latin America
8.10.1 Melcon Partnership and Other Growth Strategies for Teuto
8.11 Biolab Farmaceutica Leads Cardiology Drugs Market
8.11.1 Partnering With German and Indian Companies
8.11.2 Current Pipeline and Product Launches
8.12 Cristalia: Largest Producer of Anaesthetics in Latin America
8.12.1 Approval from ANVISA to Produce Biosimilar Drugs
8.12.2 Leader in API Manufacturing
8.12.3 Involved in One Third of all PDPs
8.13 Libbs: Key Player in Cancer Treatment
8.13.1 Libbs Secures $106m in Funding from BNDES for New Biotechnology Facility
8.14 União Quimica: Huge Annual Production Capacity
8.14.1 Agreement with Novartis and Possible Public Offering in 2015
8.15 Other Domestic Players Include Laboratório Daudt Oliveira and Hebron
8.16 Biosimilar Collaborations
8.16.1 Bionovis: Conglomerate Developing 8 Biosimilars
8.16.2 Orygen: Conglomerate Aiming to Develop 7 Biologics
8.16.3 Other Biotech Players Include Biomm and Innova
8.16.4 Fiocruz: At the Heart of Multiple PDPs
8.16.5 ANVISA Reform of Brazilian Patent System
9. Multinational Companies in the Brazilian Market
9.1 The Top Ten Multinational Pharmaceutical Companies in Brazil, 2015
9.2 Notable M&A Activity
9.3 Sanofi: Medley Purchase Makes French Giant the Outright Leader
9.3.1 Group Companies Include Sanofi Pasteur and Genzyme
9.3.2 Inventory Mishandling and Dip in 2013 Results
9.4 Novartis: Only Multinational to Produce APIs in Brazil
9.4.1 PDPs and a New $342m Biotechnology Facility in the North East
9.4.2 Pricing and Reimbursement Solutions to Bring Costlier Drugs to Brazil
9.4.3 Investment in Expansion Plans
9.5 Roche: No Regrets About Staying in Brazil
9.5.1 Oncology Opportunity and Herceptin Pricing
9.6 Merck & Co. – Long-Standing Presence in the Brazilian Market
9.6.1 Five Factories and Five Broad Therapeutic Areas
9.6.2 Gardasil Added to SUS in 2013
9.6.3 Joint Venture with Eurofarma and Cristalia
9.7 Pfizer: Pursuing Strategy to Acquire Domestic Manufacturers
9.7.1 Portfolio Ranges from Orphan Biologics to Multivitamins
9.8 Takeda: Expanding its Brazilian Business
9.8.1 Acquisitions of Nycomed and Multilab
9.9 Bayer: Brazil is its Fifth Largest Market
9.9.1 OTC is a Major Focus in Brazil
9.10 AstraZeneca Targets Latin America
9.10.1 Struggling with Loss of Exclusivity and Patent Infringement
9.11 Boehringer Ingelheim: Pain, Cardiovascular and Respiratory Drugs Bolster Strong National Portfolio
9.11.1 Looking to Acquire OTC Brands
9.11.2 Technology Transfer Deal for Parkinson’s Disease
9.12 Merck KGaA Signed PDP with Bionovis for 8 Biosimilars
9.12.1 Two Divisions and Multiple Therapeutic Fields
9.13 Other Notable Multinationals in Brazil
9.13.1 GSK: Vaccines and Technology Transfer Opportunities
9.13.2 Abbott: Humira to Face Biosimilar Challenge in Brazil?
9.13.3 Abbott: Generics and Diagnostics-Led Growth Strategy
9.13.4 Eli Lilly: Investing in Upgrading Pharmaceutical Packaging Facility
9.13.5 Bristol-Myers Squibb: Divesting its Brazilian OTC Portfolio Rights
9.13.6 Baxter Entering Haemophilia Market Via Technology Transfer
9.13.7 Johnson & Johnson: Focusing on Consumer Health and Commodities
9.13.8 BiocadBrazil Farmaceutica
9.13.9 Amgen Signals Brazilian Intent with Bergamo Acquisition
9.13.10 Gilead, Novo Nordisk, Biogen, UCB and Meizler
9.13.11 Other Top Japanese Companies Trail Behind Takeda in Brazil
9.14 Will Multinational Generics Leaders Compete in Brazil?
9.14.1 Teva Targets Brazil
9.14.2 Mylan Acquires Agila to Boost Brazilian Strategy
9.14.3 Actavis May Target Brazil
9.14.4 Ranbaxy and Daiichi Sankyo
9.14.5 Torrent, Glenmark, Strides Arcolab and Biocon Looking to Brazil
9.14.6 Valeant: M&A Drive Into the Market
9.15 Brazil as a Pharmaceutical Research Destination
10. Qualitative Analysis of the Brazilian Pharmaceutical Market, 2016
10.1 Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis
10.1.1 A Crucial Market for the Pharmaceutical Industry
10.1.2 Government Regulation Remains an Issue
10.1.3 One of the Highest Pharmaceutical Tax Rates in the World
10.1.4 Room to Expand in Therapeutic Areas and Geographic Regions
10.1.5 Technology Transfer Uncertainties, IP Protection Doubts and Counterfeiting Issues
10.2 Social, Technological, Economic and Political (STEP) Analysis
10.2.1 Large and Ageing Population Eager to Buy Medicines
10.2.2 Shortcomings of Brazil’s Healthcare System
10.2.3 Government Aims for Greater Self-Sufficiency in Biotechnology and Health IT
10.2.4 Can Economic Growth Keep Pace with Healthcare Costs?
10.2.5 Political Environment Acts as Decisive Influence on the Market
10.2.6 Will BREXIT Affect Free Trade Negotiations with the EU?
11. Research Interviews
11.1 Interview With Vitor Zani, Business Development Coordinator, BiocadBrazil Farmaceutica
11.1.1 On Gaining Access to the Brazilian Market
11.1.2 Factors That Differentiate Brazil From Other Markets
11.1.3 The Brazilian Generics and Biosimilars Market and Biocad’s Progress with Biosimilars
11.1.4 Biocad’s Brazilian Pipeline, its Progress in 2014 and its Prospects for the Future
11.1.5 Development of the Brazilian Pharmaceutical Market 2015-2025; Drivers for Growth and Opportunity in the North East
11.1.6 Effect of the 2014 World Cup on the Brazilian Pharmaceutical Market and How the 2016 Olympics Will Compare
11.1.7 Strengths and Weaknesses of the Brazilian Pharmaceutical Market and Whether the Weaknesses Will Improve in Coming Years
11.2 Interview with André Brazay, President of Sandoz Brazil
11.2.1 Impact of Current Political and Economic Situation
11.2.2 Challenges faced by Domestic Companies
11.2.3 How Generics Market in Brazil Differs from Other Countries
11.2.4 Importance of Biosimilars in Brazil
11.2.5 Factors for an Overseas Investor to Consider
11.2.6 Future Challenges for the Market in Brazil
12. Conclusions from Our Research and Analysis
12.1 Growth of Brazil’s Pharmaceutical Market Will Outstrip That of More Developed Countries
12.2 Generics Will be Major Driver of Growth
12.3 Technology Transfer Boosts Domestic Production of Originator Drugs
12.4 Generics Market Provides Alternative Option for Multinationals
12.5 Oncology is Leading Therapeutic and Commercial Opportunity
12.6 Concluding Comments
【レポート販売概要】
■ タイトル：医薬品のブラジル市場見通し2016-2026■ 英文：Brazilian Pharmaceutical Market Outlook 2016-2026
■ 発行日：2016年9月
■ 調査会社：visiongain
■ 商品コード：VGAIN60905
■ 調査対象地域：ブラジル
- Arthroscopy Devices Market to 2018 – Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Future GrowthArthroscopy Devices Market to 2018 - Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Future Growth Summary GBI Research’s report, “Arthroscopy Devices Market to 2018 - Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Future Growth” looks at the market landscape, competitive landscape, and market tren …
- RV車両用ジェネレーターの世界市場ABSTRACTAbout Recreational Vehicles Generator RV generators are portable gas or diesel generators used to power appliances within a recreational vehicle and recharge its battery. Technavio’s analysts forecast the global recreational vehicles generator market to grow at a CAGR of 7.17% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospe …
- 世界のスマートウィンドウ（Smart Window）市場動向（2014-2021）NanoMarkets has now been tracking the smart windows for five years and has produced detailed studies of this market and related businesses including the smart windows materials markets and smart auto glass. Our understanding of new high-tech glass markets has been further enhanced by our studies of BIPV glass, self-healing and self-cleaning glass and various segments of the display glass sector. A …
- 世界の整形外科用電動器具（医療機器）市場MediPoint: Orthopedic Power Tools - Global Analysis and Market Forecasts Summary A power tool is a key instrument in the armamentarium of the operating room for many orthopedic surgeries. The adoption rates for orthopedic power tools vary in different regions, mainly due to price sensitivity. Globally, and driven by the orthopedic industry’s continued innovation in cordless battery-powered systems …
- コネクタの世界市場2016-2020About Connectors A connector is a device that carries electricity or electronic signals, and connects the input/output (I/O) of an electronic or electrical device with the internal controls of a machine or another device. Connectors are important in the initial setup of any industry. Use of cheap or low-grade connectors may result in weaker signals and inefficiency. The lesser the interference pro …
- コグニティブ・アナリティクスの世界市場予測（～2022年）“Proliferation of data and the rise in adoption of cognitive computing are the major factors driving the growth of the cognitive analytics market.”MarketsandMarkets forecasts the global cognitive analytics market to grow from USD 1.84 billion in 2017 to USD 10.95 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 42.9% during the forecast period. The cognitive analytics market is growing …
- ネットワーク管理ソフトウェアの世界市場2015-2019About Network Management Software Network management software manages computer networks that are spread over a wide range of network devices and software. The software is used to monitor, control, configure, troubleshoot, plan, allocate, deploy, and coordinate network-based business operations. This software also enables network managers to supervise the individual components within the network ma …
- アジアの銀行IT支出市場About banking IT spending Banking enterprises across APEJ have become increasingly dependent on various advanced technologies, and various IT products and services to run their business and drive revenue growth. This trend is expected to intensify, with the role of IT becoming vital and directly contributing to the organization’s agenda. Banks across the globe are adopting IT solutions to optimize …
- 水産養殖向け水処理技術の世界市場2016-2020About Water Treatment Market for Aquaculture Aquaculture aims to ensure viable production of seafood for commercial use; it uses a host of techniques and technologies to raise aquatic plant and animal species. Apart from producing seafood, it also helps to restore the aquatic population and makes the habitat conducive for marine organisms. It enhances the proliferation of wild fish, which live und …
- Uterine Fibroids：グローバル臨床試験レビューH2, 2013Uterine Fibroids Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Uterine Fibroids Global Clinical Trials Review, H2, 2013" provides data on the Uterine Fibroids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Fibroids. It includes an overview of the trial numbers and their recruitment statu …
- 骨移植片･代用品の世界市場分析：材料別（自然 – 自家移植片、同種移植片; 合成 – セラミック、複合体、ポリマー、骨形成タンパク質（BMP））、用途別（頭蓋顎顔面窩、歯科、足･足首、関節再建、長骨、脊椎融合）、セグメント予測The global bone graft and substitutes market is expected to reach over USD 3.6 billion by 2024, growing at an estimated CAGR of 5.2% from 2016 to 2024, according to a new study by Grand View Research, Inc. Key drivers of the market include the growing elderly population and the resultant rise in orthopedic surgeries coupled with the perpetually rising awareness regarding the benefits of commercial …
- 2014年戦略提言：スペインの呼吸器病診断検査市場About This ReportThis new 281-page report from Venture Planning Group presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. …
- 世界のシガレット（タバコ）市場2014Summary “Cigarette Top Line Data 2014” is a new report by ERC that is intended to provide key top-line data about Cigarettes in 123 markets worldwide. This report provides two basic elements, namely market volumes (consumption, trade and production) by country, region and globally and market volumes by company, by country, region and globally. Key Findings - Asia and Australasia is the biggest Cig …
- 外科手術用ステープリングデバイスの世界市場：最終用途別（病院、外来センター）、製品別（電動、手動）、種類別（再使用可能、使い捨て）、セグメント予測The global surgical stapling devices market size is anticipated to reach USD 8.02 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.23% during the forecast period. Application of surgical staplers has gradually evolved from invasive surgeries to minimally invasive surgeries. With introduction of advanced surgical staplers, difficulties associated w …
- ガラス加工装置の世界市場2016-2020About Production of Glass The production of glass involves the blending, melting, and refining of a mixture comprising high-quality sand (silica), limestone, soda ash, and cullet (crushed recycled glass). The machinery used for cutting, breaking, grinding, and drilling glass for its use in various sectors such as construction, food and beverage, automotive, and consumer electronics constitutes gla …
